SCHEMBL1861994

SCHEMBL1861994

CC(=O)NC(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669163 0.87 — —
SCHEMBL14970377 0.87 — —
SCHEMBL48989 0.87 — —
SCHEMBL20244940 0.85 — —
SCHEMBL21338510 0.85 — —
SCHEMBL13397296 0.85 CRAT (0.42) —
SCHEMBL2548083 0.85 — —
SCHEMBL12807817 0.85 — —
SCHEMBL11073459 0.83 ALDH1A1 (0.52) —
SCHEMBL14294441 0.83 ALDH1A1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220281-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COINFECTION WITH EIMERIA AND CLOSTRIDIUM CAN TECHNOLOGIES, INC. (US) 2023-11-16 — — WO disclosed
EP-4234634-A2 MODIFIED CYANINE DYES AND CONJUGATES THEREOF Bracco Imaging SPA (IT) 2023-08-30 — — EP disclosed
US-20230234978-A1 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF Atrium Therapeutics, Inc. 2023-07-27 — — US disclosed
US-20230234978-A1 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF Atrium Therapeutics, Inc. 2023-07-27 — — US disclosed
EP-3969063-B1 MODIFIED CYANINE DYES AND CONJUGATES THEREOF BRACCO IMAGING SPA (IT) 2023-07-05 — — EP disclosed
WO-2023072974-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-05-04 — — WO disclosed
US-11578090-B2 Nucleic acid-polypeptide compositions and uses thereof AVIDITY BIOSCIENCES, INC. (US) 2023-02-14 — — US disclosed
US-20210363165-A1 NITROXOLINE PRODRUG AND USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2021-11-25 — — US disclosed
CN-108530381-B Method for preparing diamine derivative from amide ester 上海科技大学 2021-09-21 — — CN disclosed
US-10869846-B2 N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress SENTIENT LIFESCIENCES, INC. (US) 2020-12-22 — — US disclosed
US-20050131016-A1 Chemical compounds ASTRAZENECA AB (SE) 2005-06-16 — — US disclosed
EP-1485371-A2 INDOLE AMIDE DERIVATIVES AND THEIR USE AS GLYCOGEN PHOSPHORYLASE INHIBITORS AstraZeneca AB (SE) 2004-12-15 — — EP disclosed
EP-1483270-A1 HETEROCYCLIC AMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE Astrazeneca AB (SE) 2004-12-08 — — EP disclosed
EP-1317459-B1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2004-04-07 — — EP disclosed
US-20030232875-A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors ASTRAZENECA AB (SE) 2003-12-18 — — US disclosed
WO-2003074513-A2 INDOLE AMIDE DERIVATIVES AND THEIR USE AS GLYCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2003-09-12 — — WO disclosed
WO-2003074532-A1 HETEROCYCLIC AMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE ASTRAZENECA AB (SE) 2003-09-12 — — WO disclosed
EP-1317459-A1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS AstraZeneca AB (SE) 2003-06-11 — — EP disclosed
WO-2002020530-A1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2002-03-14 — — WO disclosed
WO-2001058848-A1 A PROCESS FOR THE PURIFICATION OF 3-AMINO-1,2-PROPANEDIOL AND 2-AMINO-1,3-PROPANEDIOL BRACCO IMAGING S.P.A. (IT) 2001-08-16 — — WO disclosed
Send feedback